Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, and Pituitary Gland Disorders and Treatments.
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification
Updated clinical practice guidelines for the management of adult diffuse gliomas
Identifying proximity to white matter language tracts with gradient-based intraoperative electrical mapping
The default network is causally linked to creative thinking
Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases
Tumor Treating Fields (TTFields) therapy vs physicians’ choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19)
Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion
Clinical practice guidelines for the management of adult diffuse gliomas
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
The Impact of Colloid Cyst Treatment on Neurocognition
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma
Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a <i>post hoc</i> analysis of the EF-14 trial
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Response assessment of NovoTTF‐100A versus best physician's choice chemotherapy in recurrent glioblastoma
Conflicting pathology reports: a diagnostic dilemma
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality